November 6, 2018, 10:28am
This may be the reason for the fall in share price today (sound like a broken record here).
With them continuing to add cohorts it makes it difficult to determine how effective it is. What really needs to be determined is how long it takes to work and what patients of the 3 groups are seeing results.
November 6, 2018, 10:36am
I can find no other articles discussing this and I cannot find the source the author got his data from. I contacted nktr investor relations.
November 6, 2018, 11:47am
I cannot find the source the author got his data from
They got it from the recently released SITC abstracts; thus far, available only to registrants. The SITC meeting starts tomorrow and runs through the weekend.